K-ras mutation detection in colorectal cancer using the Pyrosequencing technique

Pathology Research and Practice

Volumn 203, Issue 7, 2007, Pages 489-497

  Poehlmann, Angela ^a   Kuester, Doerthe ^a   Meyer, Frank ^a   Lippert, Hans ^a   Roessner, Albert ^a   Schneider Stock, Regine ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GENOMIC DNA; GUANINE; K RAS PROTEIN; THYMINE;

ARTICLE; BIOCHEMISTRY; CANCER STAGING; CODON; COLORECTAL CANCER; COLORECTAL CARCINOMA; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; RELIABILITY; VALIDATION PROCESS;

EID: 34447519926     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.06.001     Document Type: Article

References (40)

1. Akkiprik M., Ataizi-Celikel C., Düsünceli F., Sönmez O., Güllüodlu B.M., Sav A., and Ozer A. Clinical significance of p53, K-ras and DCC gene alterations in stage I-II colorectal cancer. J. Gastrointestinal Liver Dis. 16 (2007) 11-17
2. Albitar M., Wu W.I., Feltz E., Jin G., Hirsch-Ginsberg C., Kantarjian H., and Beran M. Simplified reverse dot blot analyses for detecting of ras oncogene mutations. Mol. Diagn. 2 (1997) 169-176
3. Andreyev H.J.N., Norman A.R., Cunningham D., Oates J.R., and Clark P.A. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. J. Natl. Cancer Inst. 90 (1998) 675-684
4. Bazan V., Migliavacca M., Zanna I., Tubiolo C., Grassi N., Latteri M.A., LaFarina M., Albanese I., Dardanoni G., Salerno S., Tomasino R.M., Labianca R., and Gebbia N. A. Russo Specific codon 13 K-ras mutations are predictive of clinical outcoe in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann. Oncol. 13 (2002) 1438-1446
5. Becker C.F., Hunter C.L., Seidel R.P., Kent S.B., Goody R.S., and Engelhard M. A sensitive fluorescence monitor for the detection of activated Ras: total chemical synthesis of site-specifically labelled Ras binding domain of c-Raf1 immobilized on a surface. Chem. Biol. 8 (2001) 243-252
6. Bos J.L. The ras gene family and human carcinogenesis. Mutat. Res. 195 (1988) 255-271
7. Bos J.L., Fearon E.R., Hamilton E.R., Verlaan-de Vries M., van Boom J.H., van der E.B.A.J., and Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 327 (1987) 293-297
8. Boughdady I.S., Kisnella A.R., Haboubi N.Y., and Schofield P.F. K-ras gene mutation in adenomas and carcinomas of the colon. Surg. Oncol. 1 (1992) 275-282
9. Breivik J., Meling G.I., Spurkland A., Rognum T.O., and Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumor location. Br. J. Cancer 69 (1994) 367-371
10. Brink M., de Goeij A.F., Weijenberg M.P., Roemen G.M., Lentjes M.H., Pachen M.M., Smits K.M., de Bruine A.P., Goldbohm R.A., and van den Brandt P.A. K-ras oncogene mutations in sporadic colorectal cancer in the netherlands cohort study. Carcinogenesis 24 (2003) 703-710
11. Brink M., Weijenberg M.P., De Goeij A.F., Schouten L.J., Koedijk F.D., Roemen G.M., Lentjes M.H., De Bruine A.P., Goldbohm R.A., and Van Den Brandt P.A. Fat and K-ras mutations in sporadic colorectal cancer in the Netherlands Cohort study. Carcinogenesis 25 (2004) 1619-1628
12. Cerottini J., Caplin S., Saraga E., Givel J.C., and Benhattar J. The type of K-ras mutation determines prognosis in colorectal cancer. Am. J. Surg. 175 (1998) 198-202
13. Clayton S.J., Scott F.M., Walker J., Callaghan K., Haque K., Lioglou T., Xinarianos G., Shawcross S., Ceuppens P., Field J.K., and Fox J.C. K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation using ARMS allele-specific amplification. Clin. Chem. 46 (2000) 1929-1938
14. Colella S., Shen L., Baggerly K.A., Issa J.P., and Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis. Biotechniques 35 (2003) 146-150
15. Emanuel J.R., Damico C., Ahn S., Bautista D., and Costa J. Highly sensitive nonradioactive single-strand conformational polymorphism: detection of Ki-ras mutations. Diagn. Mol. Pathol. 5 (1996) 260-264
16. Fakhrai-Rad H., Pourmand N., and Ronaghi M. Pyrosequencing: an accurate detection platform for single nucleotide polymorphism. Hum. Mutat. 19 (2002) 479-485
17. Fearon E.R., and Vogelstein B. A genetic model for colorectal carcinogenesis. Cell 61 (1990) 759-767
18. Finkelstein S.D., Sayeg R., Christensen S., and Swalsky P.A. Genotipic classification of colorectal adenocarcinoma. Cancer 71 (1993) 3827-3838
19. Forrester K., Almoguera C., Han K., Grizzle W.E., and Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327 (1987) 298-303
20. Haynes V.M., Westra J.L., Verlind E., Bleeker W., Plukker J.T., Hofstra R.M., and Buys C.H. New comprehensive denaturing-gradient-gel-electrophoresis assay for KRAS mutation detection applied to paraffin-embedded tumours. Genes Chromosomes Cancer 4 (2000) 309-314
21. Keohavong P., Zhu D., Whiteside T.L., Swalsky P., Bakker A., Elder E.M., Siegfried J.M., Srivastava S., and Finkelstein S.D. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Anal. Biochem. 247 (1997) 394-403
22. Kislitsin D., Lerner A., Rennert G., and Lev Z. K-ras mutations in sporadic colorectal tumors in Israel: unusual high frequency of codon 13 mutations and evidence for nonhomogeneous representation of mutation subtypes. Dig. Dis. Sci. 47 (2002) 1073-1079
23. Kressner U., Bjorheim J., Westring S., Wahlberg S.S., Pahlman L., Glimelius B., Lindmark G., Lindblom A., and Borresen-Dale A.L. Ki-ras mutations and prognosis in colorectal cancer. Eur. J. Cancer 34 (1998) 518-521
24. Lilleberg S.L., Durocher J., Sanders C., Walters K., and Culver K. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform. Ann. NY Sci. 1022 (2004) 250-256
25. Lleonart M.E., Ramon y Cajal S., Groopman J.D., and Friesen M.D. Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis. Nucleic Acids Res. 32 (2004) 53
26. Martinez-Garza S.G., Nunez-Salazar A.D.J., Calderon-Garciduenas A.L., Bosques-Padilla F.J., Niderhauser-Garcia A., and Barrera-Saldana H.A. Frequency and clinicopathology associations of K-ras mutations in colorectal cancer in a northeast mexican population. Dig. Dis. 17 (1999) 225-229
27. Ogino S., Kawasaki T., Brahmandam M., Yan L., Cantor M., Namgyal C., Mino Kenudson M., Lauwers G.Y., Loda M., and Fuchs C.S. Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J. Mol. Diagn. 7 (2005) 413-421
28. Pretlow T.P., Brasitus T.A., Fulton N.C., Cheyer C., and Kaplan E.L. K-ras mutations in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 85 (1993) 200-204
29. Ronaghi M., Karamohamed S., Petterson B., Uhlen B., and Nyren P. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 242 (1996) 84-89
30. Ronaghi M., Uhlen M., and Nyren P. A sequencing method based on real-time pyrophosphate. Science 281 (1998) 363-365
31. Rothschild C.B., Brewer C.S., Loggie B., Beard G.A., and Triscott M.X. Detection of colorectal cancer K-ras mutations using a simplified oligonucleotide ligation assay. J. Immunol. Methods 206 (1997) 11-19
32. Samowitz W.S., Curtin K., Schaffer D., Robertson M., Leppert M., and Slattery M.L. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1193-1197
33. Sanger F., Nicklen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl. Acad. Sci. 74 (1977) 5463-5467
34. Schimanski C.C., Linnemann U., and Berger M.R. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res. 59 (1999) 5169-5175
35. Schneider-Stock R., Boltze C., Peters B., Szibor R., Landt O., Meyer F., and Roessner A. Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia 6 (2004) 529-535
36. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors. Sixth ed (2002), Wiley, New York
37. Vogelstein B., and Kinzler K.W. Digital PCR. Proc. Natl. Acad. Sci. USA 96 (1999) 9236-9241
38. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., and Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319 (1988) 525-532
39. Ward R., Hawkins N., O'Grady R., Sheehan C., O'Connor T., Impey H., Roberts N., Fuery C., and Tood A. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Am. J. Pathol. 153 (1998) 373-379
40. Zhao C., Xu G., Shi X., Ma J., Lu S., and Yang Q. Detection of K-ras exon 1 mutations by constant denaturant capillary electrophoresis. Biomed. Chromatogr. 8 (2004) 538-541